Orthofix Medical, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-123.00
-148.00
-17.00
-13.00
0.00
-27.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-19.00
-53.00
-29.00
-24.00
19.00
-29.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
25.00
-45.00
-11.00
18.00
74.00
32.00
Cash Flow from Investing Activities
-27.00
-33.00
-24.00
-23.00
-52.00
-22.00
Cash Flow from Financing Activities
50.00
65.00
0.00
-3.00
3.00
-10.00
Net Cash Inflow / Outflow
47.00
-12.00
-37.00
-8.00
26.00
-1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Orthofix Medical, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-123.875000000217
-127.485
4.00
2.83%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-19.2510000000338
-25.688
6.00
25.06%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
25.7900000000453
-116.303
141.00
122.17%
Cash Flow from Investing Activities
-27.5800000000484
103.938
-130.00
-126.54%
Cash Flow from Financing Activities
50.709000000089
67.87
-17.00
-25.29%
Net Cash Inflow / Outflow
47.9810000000842
55.505
-8.00
-13.56%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.938000000001646
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 156.37% vs -296.54% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
25.79
-45.75
156.37%






